Non-Small Cell Lung Cancer (NSCLC) accounts for 80–85% of all lung cancer diagnoses and poses challenges in early detection due to symptoms often resembling common illnesses or long-term smoking effects.

Digital therapies are evidence-based clinical approaches powered by software applications designed to prevent, control, or treat a particular disease or condition.

Age-related macular degeneration (AMD) is a chronic, progressive, and severe disease of the central retina and is the leading cause of irreversible vision loss.

Chronic lower back pain (CLBP) is the second leading cause of disability worldwide. The prevalence of CLBP in adults has grown significantly over the last ten years.

Cannabis culture is not new and is not restricted to recreational purposes. The use of cannabis, a.k.a. marijuana, for medicinal purposes such as joint pain, muscle spasms, gout, spinal cord injury, and insomnia, dates back to as early as 5000 BC.

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and accounted for around 85% of all lung cancers in the United States.

Acute Kidney Injury (AKI) is a condition characterized by minor or complete loss of kidney function due to a sudden injury to kidneys. AKI is different from chronic kidney disease, wherein the kidney function is lost over a period of time.

The novel coronavirus, SARS-CoV-2, also known as COVID-19, has now become a pandemic, leaving all healthcare institutions and government officials baffled, and researchers and scientists on high alert.

Every year several new drugs enter the pharma value chain. The launch of a new therapy or drug means a new treatment option for the patient pool and advancement in people’s quality of life.

Orphan disease, by definition, is “any disease that affects a small percentage of the general population.” These diseases are often life-threatening, chronic, progressive, degenerative, and disabling, while most of them are linked to a genetic disorder and remain undiagnosed.